198 studies found for:    Open Studies | "Attention Deficit Disorder with Hyperactivity"
Show Display Options
Rank Status Study
21 Recruiting The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate
22 Recruiting Omega-3 Fatty Acid Supplementation to Stimulants in Children With Attention Deficit Hyperactivity Disorder and Deficient Emotional Self-Regulation
Conditions: Attention Deficit Hyperactivity Disorder;   Deficient Emotional Self-Regulation
Interventions: Dietary Supplement: Omega-3 Fatty Acid;   Drug: Stimulant Medication
23 Unknown  The Association Between Executive Functions and Candidate Genes of Dopaminergic and Noradrenergic Systems in Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention:
24 Unknown  Transcranial Magnetic Stimulation in Treatment of Attention Deficit/Hyperactivity Disorders
Condition: Attention Deficit/Hyperactivity Disorder
Interventions: Device: Transcranial Magnetic Stimulation (Magstim, Rapid);   Other: Placebo Treatment
25 Unknown  The Effectiveness of Atomoxetine on Brain Imaging, Neuropsychological, and Social Functions in Adults With Attention Deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention:
26 Recruiting The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit/Hyperactivity Disorder Combined Type;   ADHD Predominantly Inattentive Type;   ADHD Predominantly Hyperactivity Type;   ADHD-not Other Specified
Intervention: Drug: Methylphenidate- Ritalin IR (Immediate Release)
27 Recruiting Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy
Conditions: Attention Deficit Disorder With Hyperactivity;   ADHD Inattention or Mixed Type;   Epilepsy;   Child
Interventions: Drug: Vayarin®, supplementation of n-3 PUFA;   Drug: PLACEBO
28 Recruiting Genetic, Brain Structure, and Environmental Effects on ADHD
Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
29 Not yet recruiting Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment
Condition: "Attention Deficit Hyperactivity Disorder"
Interventions: Drug: Ritalin;   Drug: Placebo
30 Recruiting RCT, Proof of Concept Study of TEAMS (Training Executive, Attention and Motor Skills) Intervention Program
Conditions: ADHD;   Attention Deficit Disorder With Hyperactivity
Interventions: Behavioral: TEAMS intervention;   Other: Control group
31 Unknown  Reducing Attention Deficit Hyperactivity Disorder in Kindergarten and Pre-Kindergarten Children
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Behavioral: Friendship Group;   Behavioral: Academic tutoring
32 Recruiting TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: TRI102-ADD-001;   Drug: Placebo
33 Unknown  Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Atomoxetine;   Drug: Methylphenidate
34 Recruiting Attention Deficit/Hyperactivity Disorder Internet Survey Study in a College Student Population
Condition: Attention Deficit Hyperactivity Disorder
Intervention:
35 Unknown  Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Guanfacine;   Drug: Methylphenidate (MPH);   Drug: Combined methylphenidate and guanfacine
36 Recruiting Adult Outcome of Children With Attention-deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention:
37 Recruiting Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia, Attention Deficit Hyperactivity Disorder and Bipolar Disorder
Conditions: Bipolar Disorder;   Schizophrenia;   Attention Deficit Disorder With Hyperactivity
Intervention:
38 Unknown  Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning
Condition: Attention Deficit Hyperactivity Disorder
Intervention:
39 Recruiting An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Naltrexone
40 Unknown  Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years